Time | Agenda |
---|---|
08:50 ~ 09:00 (10') |
Opening
|
Session Ⅰ |
Antimicrobial therapy
|
09:00 ~ 09:35 (35') |
Antibiotic anaphylaxis: prediction and prevention
![]() |
09:35 ~ 10:10 (35') |
Therapeutic options for MDR-Gram negative pathogens
![]() |
10:10 ~ 10:20 (10') |
Q & A
|
10:20 ~ 10:30 (10') |
Break
|
Session Ⅱ |
Immunocompromised host
|
10:30 ~ 11:05 (35') |
HIV treatment: domestic and international options
![]() |
11:05 ~ 11:40 (35') |
Updates in antifungal treatment
![]() |
11:40 ~ 12:15 (35') |
Current Prophylactic Strategies for HSCT / SOT
![]() |
12:15 ~ 12:30 (15') |
Q & A
|
12:30 ~ 13:30 (60') |
Lunch break
|
Session Ⅲ |
Focused issues
|
13:30 ~ 14:05 (35') |
MTB: drug susceptibility testing and rapid molecular assays
![]() |
14:05 ~ 14:40 (35') |
Controversial infectious diseases regarding congenital infections
![]() |
14:40 ~ 14:50 (10') |
Q & A
|
14:50 ~ 15:00 (10') |
Break
|
Session Ⅳ |
COVID-19, Getting the latest update
|
15:00 ~ 15:35 (35') |
COVID-19 in children
![]() |
15:35 ~ 16:10 (35') |
COVID-19 vaccine
![]() |
16:10 ~ 16:45 (35') |
국내외 코로나19 치료제 백신 개발 현황
![]() |
16:45 ~ 17:00 (15') |
Q & A
|
17:00 ~ 17:10 (10') |
Closing
|